A PEG ratio for GILD is not computable currently - the underlying PE ratio is not present. Going back to March 2026, Gilead Sciences had a PEG ratio of 0.34.
Historically, Gilead Sciences has a PEG ratio averaging 1.09 across the last eight years. The eight years high came in the Dec 2019 quarter at 15.33, reflecting peak valuation relative to growth. The bottom was reached in the Dec 2021 quarter at 0, suggesting attractive value relative to growth during that period.
| Year | PEG ratio | PE ratio | Growth YoY |
|---|---|---|---|
| 2025 | 0.01 | 17.94 | 1,700% |
| 2024 | N/A | 243.08 | -91.6% |
| 2023 | 0.74 | 17.84 | 24% |
| 2022 | N/A | 23.46 | -26.2% |
| 2021 | 0 | 14.64 | 4,860% |
| 2020 | N/A | 582.6 | -97.6% |
| 2019 | 15.33 | 15.33 | 1% |
| 2018 | 0.8 | 14.89 | 18.6% |
| 2017 | N/A | 20.24 | -64.9% |
| 2016 | N/A | 7.1 | -18.5% |
| 2015 | 0.15 | 8.18 | 55.6% |
| 2014 | 0.04 | 11.86 | 295.5% |
| 2013 | 2.13 | 37.36 | 17.5% |
| 2012 | N/A | 21.48 | -5.5% |
| 2011 | 1.59 | 11.31 | 7.1% |
| Year | PEG ratio | PE ratio | Growth YoY |
|---|---|---|---|
| Jun 2026 | N/A | N/A | -151.5% |
| Mar 2026 | 0.34 | 18.78 | 55.6% |
| Dec 2025 | 0.01 | 17.94 | 1,700% |
| Sep 2025 | 0 | 17.05 | 6,410% |
| Jun 2025 | 0.04 | 21.95 | 494.1% |
| Mar 2025 | 0.02 | 23.49 | 1,092.5% |
| Dec 2024 | N/A | 243.08 | -91.6% |
| Sep 2024 | N/A | 838.4 | -97.9% |
| Jun 2024 | N/A | 80.72 | -80.6% |
| Mar 2024 | N/A | 183.13 | -91% |
| Dec 2023 | 0.74 | 17.84 | 24% |
| Sep 2023 | 0.21 | 15.91 | 76.4% |
| Jun 2023 | 0.53 | 17.56 | 33% |
| Mar 2023 | 0.78 | 18.6 | 23.9% |
| Dec 2022 | N/A | 23.46 | -26.2% |
A PEG ratio is unavailable for GILD - the PE ratio data is negative or zero.
Across the past 3 years, GILD's PEG ratio has averaged at 0.19.
Across the past 5 years, GILD's PEG ratio has averaged at 0.23.
In the last eight years, GILD's peak PEG ratio of 15.33 occurred in the Dec 2019 quarter.
All PEG ratio stats are based on quarterly TTM periods, unless otherwise specified.